Ureteric Visualization: Vitamin B Vs 5% Dextrose in Water
NCT03089671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238
Last updated 2021-08-12
Summary
Background: The risk of ureteric injury at the time of pelvic reconstructive surgery can be as high as 3% and the American College of Obstetricians and Gynecologists has stated that intraoperative cystoscopy should be done after all such procedures. Intravenous indigo carmine was routinely given during surgery to colour the urine bright blue and allow for assessment of ureteric integrity. In 2014, indigo carmine was no longer available worldwide and since then, surgeons have been searching for suitable alternatives. Vitamin B is a water soluble vitamin that colours the urine bright yellow and can be given immediately before surgery to help with ureteric visualization. Alternatively, 5% dextrose in water (D5W) can be used as the instillation fluid during cystoscopy to allow for urine jet visualization due to the difference in fluid viscosity. Both agents have been shown to be better than instillation with normal saline and are affordable and accessible in Canada.
Objective: To identify which agent is superior for intraoperative ureteric visualization at the time of cystoscopy by determining the difference in detection rate of both ureteric jets using either preoperative oral vitamin B or intraoperative cystoscopic distension with D5W.
Methods: This study will be a three-site (Mount Sinai Hospital, Sunnybrook Health Sciences Centre, Women's College Hospital), double-blinded, randomized control trial whereby female patients undergoing pelvic reconstructive surgery will be randomized to receive either preoperative vitamin B or intraoperative D5W cystoscopic instillation fluid. Parameters measured during surgery will include whether both ureteric jets were seen, time to visualization of both ureters, colour of jets, and surgeon satisfaction. Patients will also be seen at one week after surgery to assess for urinary tract infection. Sample size calculation based on previous studies demonstrated a need for 119 patients per study arm.
Anticipated Clinical Significance: The findings of this study will be relevant to all surgeons performing intraoperative cystoscopy where ureteric visualization is required. The investigators believe the outcome of this study will help make cystoscopy shorter and more efficient for surgeons who often feel the pressure of time constraints within the operating room setting. In turn, decreasing the time of cystoscopy may reduce operating times which will benefit both the patient and hospital.
Conditions
- Pelvic Floor Disorders
- Ureter; Kink
Interventions
- OTHER
-
Vitamin B (riboflavin, vitamin B2)
Vitamin B is a natural health product approved as a colouring agent.
- OTHER
-
5% Dextrose in Water (D5W)
5% Dextrose in Water is an irrigation/instillation fluid, commonly used in intravenous lines.
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
collaborator OTHER -
Women's College Hospital
collaborator OTHER -
Mount Sinai Hospital, Canada
lead OTHER
Principal Investigators
-
Colleen D McDermott, MD · Mount Sinai Hospital, Canada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-07
- Primary Completion
- 2021-06-30
- Completion
- 2021-07-21
Countries
- Canada
Study Locations
More Related Trials
-
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
NCT03719755 ·Status: COMPLETED ·Phase: NA
-
Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries
NCT03800667 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
NCT03931408 ·Status: COMPLETED ·Phase: PHASE2
-
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
NCT03287089 ·Status: COMPLETED ·Phase: PHASE4
-
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
NCT01450800 ·Status: COMPLETED ·Phase: PHASE4
-
Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy
NCT03633994 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)
NCT06706362 ·Status: RECRUITING ·Phase: PHASE4
-
E. Coli for Prevention of Catheter UTI in SCI Patients
NCT00458471 ·Status: COMPLETED ·Phase: PHASE1
-
Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection
NCT03099863 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Satisfaction and Long-term Safety of Intravesical Aminoglycoside Instillations in UTI Prevention
NCT05376670 ·Status: COMPLETED
-
Preventing Urinary Tract Infection Post-Surgery
NCT01346774 ·Status: COMPLETED ·Phase: PHASE2
-
Bladder Morphology Using 2 Different Catheter Designs
NCT03108079 ·Status: UNKNOWN ·Phase: NA
-
Silver-Coated vs Standard Catheter for UTI Prevention
NCT05408533 ·Status: COMPLETED ·Phase: NA
-
Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter
NCT02658903 ·Status: UNKNOWN ·Phase: PHASE1
-
Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
NCT00734968 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin C for the Prevention of UTI in Women Who Undergo Elective Gynecological Surgeries
NCT04261036 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery
NCT06852248 ·Status: RECRUITING
-
Urinary Track Infection Prevention After Urogynecological Surgery
NCT03818321 ·Status: COMPLETED ·Phase: PHASE2
-
A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding
NCT02297178 ·Status: WITHDRAWN
-
Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
NCT02757417 ·Status: WITHDRAWN ·Phase: NA
-
UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery
NCT03898310 ·Status: COMPLETED ·Phase: NA
-
Vitamin C and Hiprex in rUTI
NCT06710899 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Antibiotic Prophylaxis to Prevent Post-procedure UTI After VCUG
NCT05438082 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms
NCT05276466 ·Status: UNKNOWN ·Phase: NA
-
Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women
NCT03106103 ·Status: COMPLETED